-transparent.png){kind=logo}
Intracerebroventricular (icv) injection of neurotensin (NT) (2 micrograms/rat) suppressed prolactin (PRL) release induced by L-5-hydroxytryptophan (1 mg/100 g body wt, iv), prostaglandin E2(1 microgram/rat, icv), and FK33-824 (10 micrograms/100 g body wt, iv), a Met5-enkephalin analog, in urethane-anesthetized or conscious rats. In contrast, NT did not suppress elevated plasma PRL levels sustained by a large dose of domperidone (10 micrograms/100 g body wt, iv), a peripheral dopamine antagonist. In in vitro experiments, NT (10(-5) M) stimulated dopamine release from perifused rat hypothalamic fragments. These results suggest that central NT inhibits PRL secretion by stimulating dopamine release from the hypothalamus into hypophysical portal blood in the rat.
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
November 1967,
Endocrinology,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
November 1995,
Neuroendocrinology,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
November 1987,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
December 1982,
Life sciences,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
January 1974,
Endocrine research communications,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
June 1986,
The American journal of physiology,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
December 1994,
Cell biology and toxicology,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
August 1998,
Neuroendocrinology,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
January 1977,
Advances in experimental medicine and biology,
K Tojo, and
Y Kato, and
Y Kabayama, and
H Ohta, and
T Inoue, and
H Imura
August 1991,
Endocrinologia japonica,
